Skip to main content
Emergency Medicine Kenya Foundation
  • About Us
    • Profile
    • Staff
    • Services
    • Newsletter
    • Get Involved
  • Education & Research
    • Emergency Care Updates
    • Emergency Care Algorithms
    • Clinical Guidelines
    • Our eBooks
    • Our Training Programs
    • Postgraduate Training & Other Courses
    • Research & Publications
  • Projects
    • Project 47 : Emergency Care in the Counties
    • Giving Oxygen to Emergency Patients in Kenya
    • Our Training Programs
    • Emergency Care Policies & Legislation
    • TIPSI© – The Injury Prevention and Safety Initiative
    • Emergency Care Equipment (ECUIP©)
    • Emergency Care Conferences
    • #18HoursFilm
  • Talks
    • Emergency Care Talks
    • Conferences
  • COVID-19
  • Resources
  • Press
  • Shop
  • DONATE
  • Contact us

Acute Renal Failure

SHIFTY MEDICINE: Kayexalate is a potentially harmful therapy to treat hyperkalemia

29 June, 201511 July, 2021 EMKF

Kayexalate is a potentially harmful therapy to treat hyperkalemia, it has a slow onset action (if at all) and doubtful efficacy. It also carries risk of life threatening gastrointestinal complications. There is NO CONVINCING EVIDENCE that Kayexalate increases fecal potassium losses.

Emergency Medicine Kenya Foundation - All rights reserved | Disclaimer